HC Wainwright Reiterates “Buy” Rating for Edap Tms (NASDAQ:EDAP)

HC Wainwright restated their buy rating on shares of Edap Tms (NASDAQ:EDAP) in a report published on Thursday, Benzinga reports. HC Wainwright currently has a $19.00 target price on the medical equipment provider’s stock.

Separately, StockNews.com raised shares of Edap Tms from a sell rating to a hold rating in a research note on Monday.

Edap Tms Stock Up 9.0 %

Shares of NASDAQ:EDAP opened at $3.26 on Thursday. The firm has a 50 day simple moving average of $4.68 and a 200 day simple moving average of $6.01. Edap Tms has a 52 week low of $2.71 and a 52 week high of $8.50. The company has a debt-to-equity ratio of 0.08, a quick ratio of 2.00 and a current ratio of 2.62. The company has a market cap of $120.96 million, a PE ratio of -6.04 and a beta of 0.45.

Edap Tms (NASDAQ:EDAP) last announced its quarterly earnings data on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.04). Edap Tms had a negative return on equity of 31.44% and a negative net margin of 30.12%. The business had revenue of $16.97 million during the quarter, compared to analysts’ expectations of $17.16 million. As a group, research analysts expect that Edap Tms will post -0.51 earnings per share for the current year.

Institutional Investors Weigh In On Edap Tms

Large investors have recently made changes to their positions in the company. Commonwealth Equity Services LLC lifted its stake in Edap Tms by 5.9% in the second quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after acquiring an additional 4,000 shares during the last quarter. Virtu Financial LLC bought a new position in shares of Edap Tms during the 1st quarter valued at $82,000. Miracle Mile Advisors LLC acquired a new stake in shares of Edap Tms in the 1st quarter valued at $136,000. Finally, Roubaix Capital LLC bought a new stake in Edap Tms in the first quarter worth $169,000. Institutional investors own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.